Current role of aflibercept in retinopathy of prematurity - A review
{{output}}
The introduction of intravitreal anti-vascular endothelial growth factor (VEGF) therapy has transformed the management of severe retinopathy of prematurity (ROP) in the zone I/zone II posterior region and aggressive ROP by enabling rapid disease regression whi... ...
